Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-05-02 7:28 pm Purchase |
2023-04-28 | 13D | Kinnate Biopharma Inc. KNTE |
ORBIMED ADVISORS LLC | 6,098,797 13.100% |
1,405,168 (+29.94%) |
Filing History |
| 2023-04-21 5:03 pm Sale |
2023-04-19 | 13D | TELA Bio, Inc. TELA |
ORBIMED ADVISORS LLC | 2,866,267 11.900% |
-192,000 (-6.28%) |
Filing History |
| 2023-04-11 7:10 pm Purchase |
2023-03-29 | 13D | Apollomics, Inc. APLM |
ORBIMED ADVISORS LLC | 6,626 10.300% |
6,626 (New Position) |
Filing History |
| 2023-04-07 4:38 pm Sale |
2023-04-05 | 13D | Galecto, Inc. GLTO |
ORBIMED ADVISORS LLC | 107,866 10.500% |
-2,992 (-2.70%) |
Filing History |
| 2023-03-31 4:48 pm Purchase |
2023-03-29 | 13D | Gracell Biotechnologies Inc. GRCL |
ORBIMED ADVISORS LLC | 7,583,576 11.200% |
1,612,904 (+27.01%) |
Filing History |
| 2023-03-29 5:24 pm Unchanged |
2023-03-27 | 13D | Terns Pharmaceuticals, Inc. TERN |
ORBIMED ADVISORS LLC | 7,619,135 13.400% |
0 (Unchanged) |
Filing History |
| 2023-03-24 4:57 pm Purchase |
2023-03-22 | 13D | CalciMedica, Inc. CALC |
ORBIMED ADVISORS LLC | 297,380 5.400% |
297,380 (New Position) |
Filing History |
| 2023-03-24 4:43 pm Sale |
2023-03-22 | 13D | 89bio, Inc. ETNB |
ORBIMED ADVISORS LLC | 0 0.000% |
-1,504,436 (Position Closed) |
Filing History |
| 2023-03-22 4:27 pm Purchase |
2023-03-20 | 13D | CalciMedica, Inc. CALC |
ORBIMED ADVISORS LLC | 297,380 18.900% |
297,380 (New Position) |
Filing History |
| 2023-03-14 4:19 pm Purchase |
2023-03-09 | 13D | Theseus Pharmaceuticals, Inc. THRX |
ORBIMED ADVISORS LLC | 17,233,668 39.600% |
395,000 (+2.35%) |
Filing History |
| 2023-02-28 5:09 pm Sale |
2023-02-16 | 13D | Fusion Pharmaceuticals Inc. FUSN |
ORBIMED ADVISORS LLC | 2,930,670 4.700% |
-67,311 (-2.25%) |
Filing History |
| 2023-02-28 4:00 pm Purchase |
2023-02-23 | 13D | Enliven Therapeutics, Inc. ELVN |
ORBIMED ADVISORS LLC | 8,949,339 21.800% |
8,949,339 (New Position) |
Filing History |
| 2023-02-23 3:23 pm Purchase |
2023-02-17 | 13D | Kinnate Biopharma Inc. KNTE |
ORBIMED ADVISORS LLC | 4,693,629 10.600% |
1,295,700 (+38.13%) |
Filing History |
| 2023-02-14 5:24 pm Purchase |
2022-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR |
ORBIMED ADVISORS LLC | 10,328,649 8.200% |
8,492,300 (+462.46%) |
Filing History |
| 2023-02-14 5:20 pm Sale |
2022-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN |
ORBIMED ADVISORS LLC | 0 0.000% |
-350,641 (Position Closed) |
Filing History |
| 2023-02-14 5:16 pm Purchase |
2022-12-31 | 13G | Verastem, Inc. VSTM |
ORBIMED ADVISORS LLC | 1,375,270 7.900% |
1,375,270 (New Position) |
Filing History |
| 2023-02-14 5:12 pm Purchase |
2022-12-31 | 13G | VectivBio Holding AG VECT |
ORBIMED ADVISORS LLC | 6,713,561 10.700% |
1,810,057 (+36.91%) |
Filing History |
| 2023-02-14 5:07 pm Sale |
2022-12-31 | 13G | Theravance Biopharma, Inc. TBPH |
ORBIMED ADVISORS LLC | 0 0.000% |
-5,456,780 (Position Closed) |
Filing History |
| 2023-02-14 5:04 pm Sale |
2022-12-31 | 13G | Sonendo, Inc. SONX |
ORBIMED ADVISORS LLC | 0 0.000% |
-49 (Position Closed) |
Filing History |
| 2023-02-14 4:59 pm Purchase |
2022-12-31 | 13G | SI-BONE, Inc. SIBN |
ORBIMED ADVISORS LLC | 3,201,100 9.300% |
3,201,100 (New Position) |
Filing History |